Histogen Inc reports results for the quarter ended in March - Earnings Summary

Histogen

13/05/2022 15:40

* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of 1
cent​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 7
cents per share.
    * Revenue rose 771.2% to $3.76 million from a year ago; 
analysts
expected zero. 
    * Histogen Inc's reported EPS for the quarter was a loss of
1
cent​.
    * The mean earnings estimate of analysts had fallen by
about 7.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Histogen Inc shares had fallen by 33.6% this quarter and
lost 50.1% so far this year.
    * The company reported a quarterly loss of $673 thousand.
    * Wall Street's median 12-month price target for Histogen
Inc is
$2.25 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 02:40 p.m.  ​All
figures in US dollars unless otherwise stated